Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans
- 30 November 2005
- journal article
- research article
- Published by Elsevier BV in Clinical Immunology
- Vol. 117 (2), 152-160
- https://doi.org/10.1016/j.clim.2005.07.008
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Preclinical Safety of Recombinant Human Interleukin-18Toxicologic Pathology, 2003
- Interleukin-18Journal of Leukocyte Biology, 2003
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002
- Weight Loss Reduces Interleukin-18 Levels in Obese WomenJournal of Clinical Endocrinology & Metabolism, 2002
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in VivoJournal of Clinical Endocrinology & Metabolism, 1997
- Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting EnzymeScience, 1997
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.JCI Insight, 1995